pk 11195 and ha14-1
pk 11195 has been researched along with ha14-1 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, J; Dai, Q; Freeman, A; Lee, RM; Liu, J | 1 |
Bradacs, G; Grabowski, P; Heine, B; Höpfner, M; Krahn, A; Maaser, K; Scherübl, H; Schuppan, D; Somasundaram, R; Stein, H; Sutter, AP; Vormbrock, K; Zeitz, M | 1 |
Other Studies
2 other study(ies) available for pk 11195 and ha14-1
Article | Year |
---|---|
The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzopyrans; Blotting, Western; Caspase Inhibitors; Caspases; Cell Survival; Cell-Free System; Cells, Cultured; Coloring Agents; Cytochrome c Group; Cytosol; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; In Situ Nick-End Labeling; Isoquinolines; Mice; Microscopy, Fluorescence; Mitochondria; Nitriles; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Time Factors | 2002 |
Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Benzopyrans; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cell Line, Tumor; Docetaxel; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Humans; Isoquinolines; Ligands; Liver Neoplasms; Nitriles; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Receptors, GABA-A; RNA, Messenger; Taxoids; Tritium | 2004 |